Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1991-04-16
1992-02-04
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
128659, 252625, A61K 4300
Patent
active
050858483
ABSTRACT:
A ferric hydroxide colloid having an alpha-emitting radionuclide essentially on the outer surfaces and a method of forming same. The method includes oxidizing a ferrous hydroxide to ferric hydroxide in the presence of a preselected radionuclide to form a colloid having the radionuclide on the outer surface thereof, and thereafter washing the colloid, and suspending the washed colloid in a suitable solution. The labelled colloid is useful in cancer therapy and for the treatment of inflamed joints.
REFERENCES:
patent: Re29066 (1976-12-01), Evans
patent: 3962412 (1976-06-01), Wolfangel
patent: 4057616 (1977-11-01), Wolfangel
patent: 4752464 (1988-06-01), Lieberman et al.
patent: 4970062 (1990-11-01), Atcher et al.
Atcher Robert W.
Hines John J.
Anderson Thomas G.
Maples John S.
Moser William R.
The United States of America as represented by the United States
Weinberger James W.
LandOfFree
Method of treating inflammatory diseases using a radiolabeled fe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating inflammatory diseases using a radiolabeled fe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating inflammatory diseases using a radiolabeled fe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-346629